DVA — DAVITA INC.
—
NYSE ·
Health Care ·
Health Care Providers & Services ·
CIK 927066 ·
Last close
$173.00
Market Cap
$10.88B
52W High
$247.49
52W Low
$101.00
ADV30
782,609
Next earnings
2026-10-29
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 3,578,126,000 | 1,127,079,000 | 553,194,000 | 222,931,000 | 17,816,512,000 | 495,629,000 | 16,690,695,000 |
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 3,415,548,000 | 1,073,291,000 | 473,548,000 | 197,530,000 | 17,499,365,000 | 644,243,000 | 16,451,199,000 |
| Dec 2025 | 3,619,787,000 | 1,210,270,000 | 551,205,000 | 234,217,000 | 17,480,103,000 | 676,438,000 | 16,321,665,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$2,221,916,000
Investing CF
$-984,843,000
Financing CF
$-1,481,162,000
CapEx
$-573,020,000
Dividends Paid
—
Buybacks
$-1,304,738,000
EPS Diluted TTM
$13.58
As of
2026-11-01
Balance + Analyst (yfinance extras)
Retained Earnings
$301,565,000
Inventory
$161,464,000
Receivables
$3,122,280,000
ST Investments
$70,673,000
EBIT TTM
$1,985,459,000
Pretax Income TTM
$1,391,503,000
Interest Exp TTM
$593,956,000
Analysts
7
Yahoo Snapshot (yfinance, live)
Total Revenue
$14,167,544,832
EBITDA
$2,846,491,904
Free Cash Flow
$905,084,352
Enterprise Value
$26,336,778,240
Total Cash
$566,302,016
Total Debt
$13,392,425,984
Shares Out
62,900,000
Trailing EPS
$13.21
Book Value
$-9.32
ROE
96.8%
ROA
7.6%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 13,643,069,000 | 2,010,615,000 | 746,803,000 | 17,480,103,000 | 16,321,665,000 | -651,082,000 | 1,886,500,000 |
| Dec 2024 | 12,815,550,000 | 1,954,828,000 | 936,342,000 | 17,285,268,000 | 15,193,917,000 | 121,122,000 | 2,022,038,000 |
| Dec 2023 | 12,140,147,000 | 1,601,003,000 | 691,535,000 | 16,893,578,000 | 14,150,228,000 | 1,056,097,000 | 2,059,031,000 |
| Dec 2022 | 11,609,894,000 | 1,312,542,000 | 560,400,000 | 16,928,252,000 | 14,703,452,000 | 712,326,000 | 1,564,570,000 |
TTM Snapshot
Revenues TTM
$14,009,646,000
NetIncome TTM
$847,476,000
OpCashFlow TTM
—
Assets (Latest)
$17,709,489,000
Forward EPS
$16.92
Max Pain — expiry 2026-12-18
max pain strike: $170.00 · spot: $161.79 · call oi: 11,396 · put oi: 14,082
Expected Move to 2026-12-18:
±$14.80
(9.15%) —
implied range
$146.99 –
$176.59
· ATM straddle on $160.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ENSG | ENSIGN GROUP, INC | $10.85B | $186.02 | — |
| FMS | Fresenius Medical Care AG | $11.54B | $21.69 | — |
| UHS | UNIVERSAL HEALTH SERVICES INC | $9.92B | $191.98 | — |
| EHC | Encompass Health Corp | $13.53B | $137.88 | — |
| BTSG | BrightSpring Health Services, Inc. | $13.90B | $69.83 | — |
News headlines (Yahoo Finance, 1h cache)
DaVita Expands Availability of Advanced Dialysis Therapy to Every U.S. Center
2026-11-17 11:00 · Yahoo
Why Is Everyone Ignoring DaVita Stock's High Cash Yield?
2026-11-16 23:13 · Yahoo
Is Wall Street Bullish or Bearish on DaVita Stock?
2026-11-13 14:59 · Yahoo
DaVita Expects Fewer Dialysis Treatments in Q4, but Higher Revenue per Visit Could Help Offset the Drop
2026-11-13 08:14 · Yahoo
DaVita Sees Growth and Drug Savings Offsetting 2027 Reimbursement Pressure
2026-11-10 10:12 · Yahoo
Investors Heavily Search DaVita Inc. (DVA): Here is What You Need to Know
2026-11-05 13:00 · Yahoo
DaVita Inc. to Participate in Upcoming Investor Conferences
2026-11-03 21:05 · Yahoo
What Does DaVita (DVA) Stock Risk From The HHS Reform Probe?
2026-11-01 15:14 · Yahoo
DaVita (DVA) Q3 2026 Earnings Call Transcript
2026-10-30 14:29 · Yahoo
DaVita Q3 Earnings Beat Estimates on IKC Strength, Revenues Rise Y/Y
2026-10-30 13:57 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.